Molina Healthcare earnings date
Want to see MOH full AI Analyst Report?
Molina Healthcare (MOH) Q3 2026 Earnings Report
MOH Q3 2026 EPS Results
- Actual EPS
- $0.89
- Consensus EPS
- $0.79
- Beat/Miss
- Beat by +$0.10
- One Year Ago EPS
- $1.84
MOH Q3 2026 Revenue Results
- Actual Revenue
- $11.08B
- Expected Revenue
- $10.86B
- Beat/Miss
- Beat by +$226.65M
- YoY Revenue Growth
- -3.44%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/21/2026
- Time
- After Close
- Conference Call
- Wednesday, October 21, 2026
Molina Healthcare's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was broadly optimistic. Third-quarter results were in line with expectations, 2026 guidance was reaffirmed, the balance sheet remained strong, and management highlighted improving Medicaid rate conditions, strong duals performance, the successful Florida CMS implementation, and preliminary 2027 earnings building blocks above $9.50 per share. The main challenges were elevated medical cost trend, membership declines, current-year MAPD and Marketplace losses, the initial Florida CMS loss, and delays to the Georgia and Texas contracts. Overall, the number and significance of the positive developments outweighed the stated challenges.
For 2026, Molina reaffirmed premium revenue guidance of approximately $42 billion and adjusted earnings guidance of at least $5.25 per share, with consolidated MCR at 92.6%, adjusted G&A ratio at approximately 6.4%, Medicaid MCR at 92.9%, Medicare MCR at 92.2%, and Marketplace MCR at 90%; guidance now includes rates at 4.5% and trend at 5.5%, with implied fourth quarter adjusted EPS of $0.50, Medicaid MCR of 93.6% (92.5% excluding Florida CMS), Medicare MCR of 94.7%, and Marketplace MCR of 96.1%. For 2027, premium revenue is expected to be at least $45 billion, preliminary EPS building blocks sum to more than $9.50 per share, known embedded earnings remain approximately $9 per share, and $4 per share of embedded earnings is expected to be harvested, while Medicaid rates may approximate 6%, medical cost trend is projected in a range of 5.5%-6% including 50 basis points of conservatism, membership attrition is expected to be 6%, Marketplace is expected to reach at least breakeven, and every 100 basis points of Medicaid MCR is worth approximately $5 per share.
- Third-Quarter Results Met ExpectationsMolina reported approximately $10.5 billion of premium revenue, adjusted EPS of $0.89, a 92.9% consolidated MCR, a 6.3% adjusted G&A ratio, and a 0.6% adjusted pre-tax margin for the third quarter. Year-to-date adjusted pre-tax margin was 1.1%.
- 2026 Guidance ReaffirmedFull-year 2026 premium revenue guidance remains approximately $42 billion, and adjusted EPS guidance remains at least $5.25 per share. Consolidated MCR guidance remains 92.6%, adjusted G&A ratio guidance remains approximately 6.4%, and embedded earnings remain approximately $9 per share.
- Medicaid Results and Rate OutlookThird-quarter Medicaid MCR was 93%, in line with expectations, as rate updates largely offset a slight increase in medical costs. Full-year Medicaid MCR guidance remains 92.9%, while the full-year rate outlook increased from 4%-4.5% to 4.5% due to off-cycle and on-cycle rate updates. The legacy Medicaid business is projected to achieve a 1.6% pre-tax margin and contribute approximately $5.75 per share for 2026.
- Improving Underlying Medicaid PerformanceExcluding the Florida CMS contract, underlying Medicaid MCR is expected to improve by approximately 50 to 60 basis points in the fourth quarter due to the rate cycle and normal seasonality. Management stated that the underlying Medicaid MCR improving by 50 basis points is a positive development.
- Medicare Duals PerformanceThird-quarter Medicare MCR was 93%, in line with expectations, supported by continued strong performance in the duals products. The duals business is expected to produce a 1.4% pre-tax margin and contribute $1.25 per share in 2026, while the full-year Medicare segment is expected to contribute approximately $0.25 per share.
- Strong Balance Sheet and LiquidityMolina harvested $185 million of subsidiary dividends during the quarter. Parent-company cash was approximately $600 million, operating cash flow for the first nine months of 2026 was $629 million, and net debt-to-capital was 45%. Management said it has ample cash and access to capital to support growth initiatives.
- Florida CMS Contract ImplementationThe $6 billion Florida CMS contract added 115,000 members and was described as having an almost flawless operational and clinical implementation during its first 22 days. Management said the contract appears structurally intact, with rates appearing to capture program costs, and remains confident in reaching break-even or better next year and the full target margin in year two.
- 2027 Earnings Building BlocksPreliminary 2027 adjusted EPS building blocks total more than $9.50 per share from known items, beginning with at least $5.25 per share of 2026 guidance, approximately $4 of known embedded earnings realization, and $0.75 assuming Marketplace reaches at least breakeven. These building blocks do not yet include any improvement in legacy Medicaid or Medicare MCRs.
- Embedded Earnings RealizationMolina expects to harvest approximately $4 per share of embedded earnings in 2027. The components include $1.50 from current-year losses on the Florida CMS contract running at breakeven or better next year, $1 from current-year MAPD losses that will not recur, and $1.50 from operating leverage associated with higher revenues.
- Medicaid Rate and Trend Setup for 2027Known January 1 rates average approximately 7% across 80% of the 55% renewal cohort. Including carryover rates, Molina knows rates on 70% of full-year 2027 premium, and overall 2027 rate increases may approximate 6%. Medical cost trend is projected at 5.5%-6%, including 50 basis points of conservatism, with management stating that rates should at a minimum capture trend.
- Potential Medicaid Margin ImprovementManagement said the imbalance between Medicaid rates and medical cost trend appears to have stabilized and that current Medicaid margins represent the trough in a multi-year cycle. The legacy Medicaid MCR is expected to be at least flat year-over-year in 2027, with potential for margin improvement. Each 100 basis points of Medicaid MCR is worth approximately $5 per share.
- Medicare Duals Growth StrategyMolina said its duals business is building on strong 2026 performance as it seeks to grow profitably. Management stated that its 2027 bids are favorable and that supplemental benefits are competitive in most markets.
- Marketplace Footprint OptimizationMolina plans to reduce its Marketplace footprint to seven states while maintaining adequate scale in each market. Management said this will allow the company to enter 2027 with risk scores commensurate with the acuity of the retained population, and the reduced footprint and pricing strategy are expected to prevent the 2026 loss from recurring.
- RFP Pipeline and Growth OpportunitiesMolina remains bullish on its RFP pipeline. It has submitted bids for Texas STAR Kids, Missouri, and Arizona, with the Indiana bid to be finalized soon. These RFPs represent approximately $26 billion of the $90 billion total opportunity highlighted at Investor Day. Management also said the Florida CMS contract is off to a great start and expressed confidence in favorable RFP award outcomes.
- Work-Requirement Readiness and State PoliciesManagement said approximately 80% of its states are leaning toward policies that promote enrollment rather than disenrollment, including ex parte reviews, flexible medical or hardship exemptions, and self-attestation. Six states included explicit January 1 adjustments for expected work requirements and redeterminations, and CMS has encouraged state actuaries to capture potential acuity shifts in rates.
- Nebraska Early ResultsNebraska's early work-requirement rollout is progressing in line with initial expectations, with management describing the impact as moderate. The state reported that 90% of renewing members were re-enrolled, including 20% through medical-frailty exemptions.
MOH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | 0.52- | -2.75 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 0.790.89 | 1.84 | -51.63% (-0.95) | |
| Jul 22, 2026 | 2026 (Q2) | 1.391.51 | 5.48 | -72.45% (-3.97) | |
| Apr 22, 2026 | 2026 (Q1) | 1.902.35 | 6.08 | -61.35% (-3.73) | |
| Feb 05, 2026 | 2025 (Q4) | 0.34-2.75 | 5.05 | -154.46% (-7.80) | |
| Jul 23, 2025 | 2025 (Q2) | 5.625.48 | 5.86 | -6.48% (-0.38) | |
| Jul 23, 2025 | 2025 (Q3) | 3.901.84 | 6.01 | -69.38% (-4.17) | |
| Apr 23, 2025 | 2025 (Q1) | 5.976.08 | 5.73 | 6.11% (+0.35) | |
| Feb 05, 2025 | 2024 (Q4) | 5.755.05 | 4.38 | 15.30% (+0.67) | |
| Oct 23, 2024 | 2024 (Q3) | 5.806.01 | 5.05 | 19.01% (+0.96) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

